相关产品推荐更多 >

TSHR Polyclonal Antibody
询价
CKM (Human) IP-WB Antibody Pair/CKM (Human) IP-WB Antibody Pair/CKM (Human) IP-WB Antibody Pair
询价
Duo 多克隆抗体
询价
TUSC3 polyclonal antibody/TUSC3 polyclonal antibody/TUSC3 polyclonal antibody
询价
MXD3 purified MaxPab mouse polyclonal antibody (B01P)/MXD3 purified MaxPab mouse polyclonal antibody (B01P)/MXD3 purified MaxPab mouse polyclonal antibody (B01P)
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
免疫原详情见datasheet,该抗体亚型为:IgG2a, kappa
- 保存条件:
-2°C-8°C
- 保质期:
1年
- 库存:
100
- 供应商:
艾美捷科技
- 宿主:
Mouse
- 应用范围:
ELISA,Neutralization
- 抗体英文名:
Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody
- 抗体名:
Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody
Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody,Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody,Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody,Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody
产品名称:Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody-Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody
产品货号:BGT-ANT-37336
产品规格:100ug#1mg

应用类型:ELISA,Neutralization

蛋白别名:IgG Fc fragment receptor transporter alpha chain, IgG receptor FcRn large subunit p51, FcRn, FCGRT, FCRN, Neonatal Fc receptor

Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody-Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody详情见产品datasheet
点击:Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody-Human FCGRT/FCRN Antibody, InVivo Block/Neutralizing Antibody更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验consists of a cooperation between monocytes and cytophilic antibodies able to bind to the Fc receptors present on the monocyte surface. Thus human IgG1 and IgG3 are the main isotypes effective in ADCI, whereas IgG2, IgG4, and IgM are ineffective
Uptake of Antigen-Antibody Complexes by Human Dendritic Cells
Fc receptors specific for IgG (FcγR) potentiate the immune response by facilitating the interaction between myeloid cells and antibody-coated targets (1 -3 ). Monocyte and neutrophil FcyR engagement can lead to the induction of lytic-type
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
技术资料暂无技术资料 索取技术资料





